Catalyst Wire Dossier Catalyst Wire Dossier

Changkang Granules

· Tasly Pharmaceutical Group Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Changkang Granules, covering 2024-12-31 to 2024-12-31. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern) [Phase 3]

See pricing